New Zofran Lawsuit Alleges Untimely Death Caused By Zofran Birth Defect

August 17, 2015 – – ZofranLegal.com reported that on June 10th, 2015, parents from Ohio filed a lawsuit against GlaxoSmithKline, alleging the birth defects their child developed while still in the womb occurred after the mother was prescribed Zofran. Zofran, which is also known by it’s generic name of Ondansetron, is an anti-nausea medication which has been frequently prescribed to pregnant women during their first trimester.

A Brief History of Zofran:

Zofran was initially approved in 1991, for use in patients who were suffering from nausea after undergoing chemotherapy treatments, or the nausea associated with anesthesia. GlaxoSmithKline also marketed the medication for use in nausea commonly associated with pregnancy. However the FDA never approved the drug for use in pregnant women, and labeled the drug a Pregnancy Category B medication. This category means that there was not enough evidence or research performed to determine if Zofran was safe to take during pregnancy.

In 2012 GlaxoSmithKline was charged with promoting “off-label” use of Zofran as a solution to nausea associated with pregnancy by the US Justice Department.

The Ohio Lawsuit:

On March 17th, 2006, a baby in Ohio was born and diagnosed with a birth defect of the heart, more specifically the right ventricle. The mother has stated that she was prescribed Zofran to help manage her nausea during the first trimester of her pregnancy. According to the complaint, the pregnancy progressed normally until a few days prior to the delivery of the baby. At that time the fetal heart rate became abnormally slow, and post delivery it was determined that the baby had a congenital defect of the heart. Despite the best efforts of her doctors, the child only survived a total of three days before she suffered from a cardiac arrest and died.

The plaintiffs have cited several studies which have reported that pregnant women who took Zofran during their first trimester are at greater risk for developing several birth defects, including but not limited to, cardiac birth defects.

What Should You Do If You Took Zofran and Your Child Was Born with a Birth Defect?

The number of lawsuits, all alleging that Zofran caused birth defects such as cardiac defects, cleft palates, and kidney defects is growing at a rapid pace. If you are concerned that your child’s birth defect was caused by Zofran don’t hesitate in contacting an attorney to determine what your legal options are.

For questions relating to this press release, contact Michael Monheit, Esquire of ZofranLegal.com on 877-620-8411.

###

Contact ZofranLegal.com:

Michael Monheit
1-877-620-8411
michael@monheit.com
1368 Barrowdale Road, Rydal, PA 19046

ReleaseID: 60003483